# Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

> **NCT00038506** · PHASE4 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 100 (—)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** abacavir/lamivudine/zidovudine
- **DRUG:** tenofovir

## Key facts

- **NCT ID:** NCT00038506
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2004-08
- **Final completion:** 2004-08
- **Target enrollment:** 100 (—)
- **Last updated:** 2015-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038506, "Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00038506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*